Objective To develop a fluorescence method for Vibrio parahaemolyticus detection by the combination of CRISPR system and the hybridization chain reaction (HCR), thus achieving rapid, sensitive, and accurate detection of the pathogen. Methods Cascade probe (RP/I) and HCR hairpin structures were first designed according to a specific conserved sequences screened from V. parahaemolyticus. Subsequently, the feasibility, specificity, and sensitivity of the method were evaluated after the optimization of reaction conditions. Furthermore, V. parahaemolyticus-contaminated aquatic products were used to validate the interference resistance of the method. Results The cleavage of CRISPR/Cas13a was activated upon binding to the target RNA (T-RNA), leading to the trans-cleavage of the RP/I cascade probe and the release of I strand. Then, the released I strand subsequently triggered HCR, generating a significant fluorescence signal for target detection. The established method successfully distinguished target sequences with single-base, double-base, and triple-base mismatches and enabled the specific identification of V. parahaemolyticus against other non-target bacteria, including V. alginolyticus, V. vulnificus, V. harveyi, V. cholerae, and Escherichia coli, demonstrating excellent specificity. The assay showed a good linear correlation over a T-RNA concentration range of 25 pmol/L to 10 nmol/L. The corresponding linear regression equation was y=7 236.75×lg C_T-RNA-8 590.11 (R²=0.99, C represents the T-RNA concentration and y represents the fluorescence intensity), with the LOD of 1.01 pmol/L. The proposed method enabled rapid detection of RNA extracted from V. parahaemolyticus in various aquatic products, yielding results consistent with those obtained by RT-qPCR. Conclusion The fluorescence method based on CRISPR/Cas13a-HCR established in this study realizes rapid detection of V. parahaemolyticus, demonstrating good sensitivity, specificity, and accuracy.

Plant endophytes are non-pathogenic microbial groups residing inside or in the interstices of plant tissue. They constitute a pivotal component of the plant microecological environment. These organisms are distinguished by their remarkable biodiversity and wide distribution across diverse regions of the host plant. Plant endophytes exhibit high species diversity, host plant diversity, habitat diversity, and functional diversity. They can secrete hormones that regulate plant growth and enhance the nutrient absorption capacity of their hosts to promote plant growth. Additionally, endophytes can promote plant growth indirectly by enhancing the host plant resistance to abiotic and biotic stresses. Notably, these endophytes are capable of producing substantial secondary metabolites, which exhibit antimicrobial, antiviral, antioxidant, and other biological activities. This capacity offers considerable potential for the development of novel pharmaceuticals, the extraction of natural products, and the creation of biopesticides. Endophytes have a wide range of applications in agriculture, industry, and medicine. They can be used as biocontrol agents to enhance crop yields or used for the production of natural pigments and perfumes and the development of novel pharmaceuticals. However, the research on plant endophytes still faces many challenges in species identification and function verification, molecular mechanism analysis of endophyte-host interactions, practical application technology, and safety evaluation.

Objective To investigate the effect of Kelch-like ECH-associated protein 1 (KEAP1) on the replication of herpes simplex virus type 1 (HSV-1) and thus provide theoretical support for anti-herpes simplex virus research. Methods The mRNA and protein levels of molecules in the KEAP1-NRF2 signaling pathway and viral molecules in ARPE-19 cells infected with HSV-1 were determined by qPCR and Western blotting, respectively. KEAP1-silenced and overexpressing ARPE-19 cell lines were constructed, and Western blotting was employed to assess the effects of KEAP1 silencing and overexpression on the nuclear factor erythroid 2-related factor 2 (NRF2) signaling pathway. The KEAP1-silenced and overexpressing cell lines were subsequently infected with HSV-1. Changes in viral mRNA expression were detected via qPCR, while immunofluorescence and Western blotting were used to evaluate alterations in viral protein expression. Additionally, a plaque formation assay was conducted to measure variations in viral titer. Western blotting was performed on KEAP1-silenced cell lines infected with HSV-1 to assess the expression levels of NRF2 signaling pathway and viral proteins at different time points. Results Silencing of KEAP1 activated the NRF2 signaling pathway and promoted HSV-1 replication, whereas KEAP1 overexpression downregulated the NRF2 signaling pathway and inhibited HSV-1 replication. These findings contradict previous studies suggesting that upregulation and activation of the NRF2 signaling pathway can suppress HSV-1 replication. Further investigation revealed that KEAP1 silencing-induced NRF2 upregulation was significantly inhibited following HSV-1 infection. Conclusion KEAP1 plays a crucial role in the host cell resistance to HSV-1 infection, and its interaction with NRF2 exerts complex biological functions in antiviral immune responses.

Sulfate-reducing bacteria (SRB) with unique reductive capabilities enable simultaneous sulfate reduction and heavy metal removal, demonstrating potential in heavy metal pollution remediation. Objective To isolate efficient SRB strains from marine sediments and investigate their reductive characteristics and application prospects in Cr(VI) contamination remediation. Methods We enriched and screened out an efficient SRB strain and systematically analyzed its sulfate reduction efficiency, Cr(VI) removal efficiency, and metabolic responses under environmental stressors (such as pH, sulfate concentration, and heavy metal concentration). This strain was then used to synthesize biological iron sulfide composite, the physicochemical characteristics of which were then investigated by scanning electron microscopy (SEM), X-ray diffraction (XRD), and Fourier-transform infrared spectroscopy (FTIR). Furthermore, the feasibility of applying the biological iron sulfide composite in the remediation of Cr(VI)-contaminated environments was explored. Results Strain S5 was identified as Desulfovibrio sp. with GenBank accession number OR140726. Its protein concentration and sulfate reduction followed an S-shaped curve. This strain exhibited a certain degree of acid tolerance, with the OD₆₀₀ and sulfate reduction rate reaching 0.16±0.01 and (83.71±1.49)% at pH 5.0, respectively. The strain exhibited sulfate reduction capability in the presence of 0.5-1.3 g/L sulfate, achieving a maximum reduction rate of (92.27±1.20)%. In the presence of 10-30 mg/L Cr(VI), strain S5 demonstrated efficient Cr(VI) removal. However, when the Cr(VI) concentration was higher than 30 mg/L, the Cr(VI) removal rate of this strain decreased significantly. The biological iron sulfide composite prepared based on strain S5 was porous, amorphous, and rich in functional groups such as C=O, N-H, and Fe-S, and its Cr(VI) removal rates were above 85% and did not differ significantly when exposed to Cr(VI) at high concentrations. Conclusion Desulfovibrio sp. S5 is a strain with high efficiency of sulfate reduction and Cr(VI) removal, and the biological iron sulfide composite prepared with it can overcome the limitation of higher Cr(VI) concentration and maintain high Cr(VI) removal rate, which has obvious advantages in the remediation of Cr(VI) pollution. The results of this study can provide a scientific basis for the application of SRB in the bioremediation of Cr(VI)-polluted environments.

Pyrroloquinoline quinone (PQQ), the third oxidoreductase coenzyme discovered in the nature after nicotinamide and riboflavin, is ubiquitous in bacteria, fungi, plants, and animals. PQQ participates in a variety of life activities and has anti-inflammation, anti-oxidation, cell metabolism-enhancing, and cardioprotective activities, demonstrating broad application prospects in pharmaceuticals, agriculture, food and other fields. Therefore, the large-scale production of PQQ is the primary problem that needs to be solved at present. Microbial fermentation is a primary production method of PQQ. Deciphering the biosynthesis pathway and regulatory mechanism of PQQ is essential for the screening and breeding of strains with short production periods and high yields by metabolic engineering, which has been a hot topic in this field. This paper summarizes the synthesis pathways, strain screening and breeding, microbial production, and purification processes of PQQ, aiming to provide a reference for further research and application of PQQ.

Siderophores are low-molecular-weight, high-affinity iron-chelating molecules produced by bacteria in response to iron deficiency. Pseudomonas secrete siderophores to efficiently chelate insoluble Fe³⁺ in the environment, which is a crucial mechanism for their adaptation to iron-limited conditions. This article systematically reviews the types, structural characteristics, biosynthetic pathways (the non-ribosomal peptide synthetase,NRPS), and regulatory mechanisms of siderophores in Pseudomonas. Several regulatory factors at multiple levels were vitally elucidated, including Fur protein, σ factors, quorum sensing, and two-component system. Moreover, siderophores not only promote iron absorption in plants and bioremediation to remove pollutants but also are virulence factors in pathogen infection and factors in microbial spoilage. The siderophore-iron complex can be specifically recognized and actively taken up by bacteria, which is known as the “Trojan horse” mechanism, enabling covalently conjugated antibiotics to enter the cell and thus significantly boosting antibiotic efficacy. Future research should delve into the molecular regulatory networks and microbial interaction mechanisms to promote the application and development of siderophores in agriculture, medicine, and environmental protection.

Irritable bowel syndrome (IBS) is a functional gastrointestinal disorder characterized by abdominal pain, abdominal distension, and abnormal bowel movements. Its pathogenesis involves multiple factors such as imbalance of gut microbiota, immune activation, and dysfunction of the gut-brain axis. Although conventional therapies can alleviate symptoms temporarily, the limitations such as drug side effects and insufficient efficacy persistence have made microbial-targeted therapy a research hotspot. Probiotics are live microorganisms and have been proven to be beneficial to human health. Studies have shown that probiotics inhibit pathogen adhesion through competitive colonization, regulate immune responses, and repair the intestinal barrier function through metabolic products, thereby improving intestinal motility and osmotic balance. This review discusses the specific effects and potential pathways of probiotics on constipation, diarrhea, abdominal pain and distension, and mental symptoms in IBS patients. However, the clinical application of probiotics still faces challenges, including strain heterogeneity, host individual differences, and the lack of standardized treatment plans. In the future, it is necessary to combine multi-omics technologies to screen biomarkers, develop individualized intervention strategies, and optimize efficacy through dynamic monitoring, which are expected to provide more precise microbial-targeted therapy for the treatment of IBS.

The global prevalence of obesity and its associated metabolic disorders keeps rising, presenting a major challenge to public health. The gut microbiota plays a pivotal role in obesity onset and development, and its dysbiosis and dysfunction are closely associated with obesity and its complications. This review synthesizes the pathological mechanisms underlying the heredity, neuroendocrine, chronic inflammation, and the gut microbiota-metabolism axis of obesity. Then, we explore the positive and negative regulatory effects of opportunistic pathogens (e.g., Desulfovibrio spp., Megamonas spp.) and putative beneficial bacteria (e.g., Lactobacillus spp., Akkermansia muciniphila) on obesity. Furthermore, we summarize the mechanisms by which these signature gut microbes drive the development of obesity-related conditions, including type 2 diabetes mellitus, metabolic dysfunction-associated steatotic liver disease, cardiovascular diseases, and hypertension. We firstly propose a gut microbiota trajectory hypothesis to delineate the interrelationships between these representative gut microbial signatures and the onset and progression of obesity and its complications. Finally, the review discusses future research directions and the potential for developing early diagnostic technologies based on these microbial signatures. Collectively, this work aims to provide novel strategies for the early diagnosis and precision intervention of obesity and related metabolic disorders, thereby advancing the development of personalized therapeutics.

Streptococcus pneumoniae is a common opportunistic pathogen that can cause various infectious diseases, including acute otitis media, bronchitis, sinusitis, community-acquired pneumonia, septicemia, and purulent meningitis. Autophagy, a lysosome-dependent intracellular degradation pathway, plays a dual regulatory role in both bacterial infection and host defense against pathogens. During S. pneumoniae infection, host cells can activate xenophagy to eliminate invading bacteria. However, this pathogen has evolved multiple evasion strategies, such as interfering with autophagosome maturation, escaping autophagic encapsulation, and even hijacking the autophagy pathway to promote intracellular survival and dissemination. Recent years have witnessed significant progress in understanding the molecular mechanisms underlying the dynamic interplay between S. pneumoniae and host autophagy systems during bacterial infection, yet a systematic review synthesizing these findings remains unavailable. This review focuses on the interaction network and key mechanisms of S. pneumoniae with host cell autophagy, aiming to provide theoretical foundations and research perspectives for developing novel targeted therapeutic strategies against S. pneumoniae infections.

China’s national food security faces rigid constraints due to land scarcity, a large population, and heavy reliance on imported feed proteins. In this context, the initiative to seek calories and proteins from microbes has become a strategic priority for building a diversified food supply system. Microbial alternative proteins represent a quintessential new quality productive force in agriculture. They offer distinct advantages, most notably high industrial efficiency and the ability to decouple protein production from food crops and arable land. This paper reviews China’s progress in this sector based on global biomanufacturing trends. The discussion focuses on synthetic biology-driven strain engineering, gas fermentation, and industrial-scale production. Furthermore, the article critically analyzes current bottlenecks, including intellectual property barriers for elite strains, high production costs, and lagging safety evaluation standards. Finally, we propose targeted recommendations to address these challenges. These include strengthening organized basic research, establishing an intelligent manufacturing system that integrates education, technology, and talents, and reforming regulatory frameworks. These insights aim to provide a strategic reference for China to secure a commanding position in the global bio-agriculture landscape.